Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy

Guy, John; Qi, Xiaoping; Pallotti, Francesco; Schon, Eric A.; Manfredi, Giovanni; Carelli, Valerio; Martinuzzi, Andrea; Hauswirth, William W.; Lewin, Alfred S.

doi:10.1002/ana.10354

Cited by 215

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy

Guy, John, Qi, Xiaoping, Pallotti, Francesco, Schon, Eric A., Manfredi, Giovanni, Carelli, Valerio, Martinuzzi, Andrea, Hauswirth, William W., Lewin, Alfred S.·2002·Annals of Neurology

DOI 10.1002/ana.10354

Open this paper in CoChat — free account

Abstract

A G to A transition at nucleotide 11778 in the ND4 subunit gene of complex I was the first point mutation in the mitochondrial genome linked to a human disease. It causes Leber Hereditary Optic Neuropathy, a disorder with oxidative phosphorylation deficiency. To overcome this defect, we made a synthetic ND4 subunit compatible with the “universal” genetic code and imported it into mitochondria by adding a mitochondrial targeting sequence. For detection we added a FLAG tag. This gene was inserted in an adeno‐associated viral vector. The ND4FLAG protein was imported into the mitochondria of cybrids harboring the G11778A mutation, where it increased their survival rate threefold, under restrictive conditions that forced the cells to rely predominantly on oxidative phosphorylation to produce ATP. Since assays of complex I activity were normal in G11778A cybrids we focused on changes in ATP synthesis using complex I substrates. The G11778A cybrids showed a 60% reduction in the rate of ATP synthesis. Relative to mock‐transfected G11778A cybrids, complemented G11778A cybrids showed a threefold increase in ATP synthesis, to a level indistinguishable from that in cybrids containing normal mitochondrial DNA. Restoration of respiration by allotopic expression opens the door for gene therapy of Leber Hereditary Optic Neuropathy.

Integrity signals

Registry

Crossref · 10.1002/ana.10354

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Multiple attempts to express mitochondrial genes allotopically have produced inconsistent and at times contradictory results.
“multiple attempts have been made to express mitochondrial genes allotopically, however results have been inconsistent and, at times, contradictory”
From Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes (2020) · cites this paper as [33]

Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Self-citation

Flagged first, then by citations

Research works printed but not linked: 37

10.1126/science.2406905 · DOI
10.1016/S0968-0004(00)01688-1 · DOI
10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P · DOI
10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L · DOI
10.1126/science.283.5407.1482 · DOI · Paper page
10.1021/bi000335t · DOI
10.1006/bbrc.1995.1740 · DOI
10.1016/0014-5793(91)80886-8 · DOI
10.1002/ana.410300511 · DOI
10.1074/jbc.M006476200 · DOI
10.1016/S0022-510X(99)00088-X · DOI
10.1073/pnas.96.9.4820 · DOI
10.1016/S0022-510X(99)00087-8 · DOI
10.1001/archopht.117.7.929 · DOI
10.1073/pnas.95.23.13847 · DOI
10.1016/S0076-6879(96)64035-X · DOI
10.1089/104303400750001381 · DOI
10.1038/ng851 · DOI · Paper page
10.1016/S0076-6879(00)16760-6 · DOI
10.1016/S0076-6879(96)64044-0 · DOI
10.1016/S0091-679X(01)65008-8 · DOI
10.1016/0167-4781(93)90249-D · DOI
10.1074/jbc.274.18.12685 · DOI
10.1074/jbc.M106363200 · DOI
10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W · DOI
10.1074/jbc.271.22.13155 · DOI
10.1136/bjo.80.1.78 · DOI
10.1097/00041327-199806000-00002 · DOI
10.1016/S0014-5793(97)00757-6 · DOI
10.1002/ana.410420407 · DOI
10.1093/hmg/11.4.431 · DOI
10.1016/S0197-0186(01)00129-2 · DOI
10.1038/82826 · DOI · Paper page
10.1006/scdb.2001.0283 · DOI
10.1001/archneur.1993.00540050082021 · DOI
Harding AE, 1995, Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation, Am J Hum Genet, 57, 77
10.1038/ng0402-345 · DOI

Sorted by citations

Mitochondrial DNA mutations and human disease
Tuppen, H. A. L., Blakely, E. L., Turnbull, D. M., & Taylor, R. W. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.09.005 · Cited by 676
“Initial attempts to recover respiratory defects in cybrids harbouring MT-ATP6 and MT-ND1 mutations, by engineered nuclear expression of their wild-type proteins [238,239], have been improved recently by forcing mRNA localisation to the mitochondrial surface, which ensures maximal mitochondrial translocation of the hig…”
Background
Gene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.025 · Cited by 230
Self-citation
Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy
Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7423 · Cited by 232
Self-citation
Hereditary optic neuropathies: from the mitochondria to the optic nerve.
Newman, N. J. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.03.017 · Cited by 209
Gene Therapy for Leber Hereditary Optic Neuropathy
Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.016 · Cited by 204
Self-citation
Leber hereditary optic neuropathy: current perspectives.
McClelland, C., Meyerson, C., & Van Stavern, G. (2015) · Clinical Ophthalmology · doi:10.2147/opth.s62021 · Cited by 196
A neurodegenerative perspective on mitochondrial optic neuropathies
Yu-Wai-Man, P., Votruba, M., Burté, F., La Morgia, C., Barboni, P., & Carelli, V. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1625-2 · Cited by 176
Self-citation
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset
Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Biousse, V., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Barboni, P., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.12.012 · Cited by 168
Self-citation
The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes
Bonnet, C., Augustin, S., Ellouze, S., Bénit, P., Bouaita, A., Rustin, P., Sahel, J.-A., & Corral-Debrinski, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.04.018 · Cited by 130
Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits
Bonnet, C., Kaltimbacher, V., Ellouze, S., Augustin, S., Bénit, P., Forster, V., Rustin, P., Sahel, J.-A., & Corral-Debrinski, M. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.0526 · Cited by 98
Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: Towards improved diagnosis and management
Newman, N. J., Yu-Wai-Man, P., Biousse, V., & Carelli, V. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00174-0 · Cited by 97
Self-citation
Trial End Points and Natural History in Patients With G11778A Leber Hereditary Optic Neuropathy: Preparation for Gene Therapy Clinical Trial
Lam, B. L., Feuer, W. J., Schiffman, J. C., Porciatti, V., Vandenbroucke, R., Rosa, P. R., Gregori, G., & Guy, J. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7971 · Cited by 96
Self-citation
Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss
Cwerman-Thibault, H., Augustin, S., Lechauve, C., Ayache, J., Ellouze, S., Sahel, J.-A., & Corral-Debrinski, M. (2015) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2015.3 · Cited by 86
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, R. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile
Koilkonda, R., Yu, H., Talla, V., Porciatti, V., Feuer, W. J., Hauswirth, W. W., Chiodo, V., Erger, K. E., Boye, S. L., Lewin, A. S., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15388 · Cited by 65
Self-citation
Dominant optic atrophy and leber’s hereditary optic neuropathy: update on clinical features and current therapeutic approaches.
Chun, B. Y., & Rizzo, J. F. (2017) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2017.06.001 · Cited by 67
Update on viral gene therapy clinical trials for retinal diseases
Cheng, S.-Y., & Punzo, C. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.159 · Cited by 49
Optimized Mitochondrial Targeting of Proteins Encoded by Modified mRNAs Rescues Cells Harboring Mutations in mtATP6
Chin, R. M., Panavas, T., Brown, J. M., & Johnson, K. K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.059 · Cited by 50
Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus
Koilkonda, R. D. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.135 · Cited by 48
Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration
Fuller-Carter, P. I., Basiri, H., Harvey, A. R., & Carvalho, L. S. (2020) · BioDrugs · doi:10.1007/s40259-020-00453-8 · Cited by 41
Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates
Calkins, D. J., Yu-Wai-Man, P., Newman, N. J., Taiel, M., Singh, P., Chalmey, C., Rogue, A., Carelli, V., Ancian, P., & Sahel, J. A. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.013 · Cited by 37
Self-citation
Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes
Lewis, C. J., Dixit, B., Batiuk, E., Hall, C. J., O'Connor, M. S., & Boominathan, A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101429 · Cited by 20
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics
Saravanan, S., Lewis, C. J., Dixit, B., O’Connor, M. S., Stolzing, A., & Boominathan, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020490 · Cited by 13
Cross-sectional analysis of baseline visual parameters in subjects recruited into the RESCUE and REVERSE ND4-LHON gene therapy studies
Moster, M. L., Sergott, R. C., Newman, N. J., Yu-Wai-Man, P., Carelli, V., Bryan, M. S., Smits, G., Biousse, V., Vignal-Clermont, C., Klopstock, T., et al. (2021) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001316 · Cited by 7
Self-citation

Authors: Guy, J., Qi, X., Pallotti, F., Schon, E. A., Manfredi, G., Carelli, V., Martinuzzi, A., Hauswirth, W. W., & Lewin, A. S.
Venue: Annals of Neurology
Publisher: Wiley
Published: 2002-10-11
Volume: 52
Issue: 5
Pages: 534-542
ISSN: 0364-5134
1531-8249
DOI: 10.1002/ana.10354
Cited by: 215
References: 3
Language: en
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks